Frazier Lifesciences Acquisition Corporation

NasdaqCM:FLAC Lagerbericht

Marktkapitalisierung: US$183.7m

This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

Die Übersetzung dieser Seite ist experimentell und in Entwicklung. Wir freuen uns über Ihr !

Frazier Lifesciences Acquisition Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 3/6

Wichtige Informationen

n/a

Verhältnis von Schulden zu Eigenkapital

US$0

Verschuldung

Zinsdeckungsgradn/a
BargeldUS$375.55k
Eigenkapital-US$11.67m
GesamtverbindlichkeitenUS$150.95m
GesamtvermögenUS$139.28m

Jüngste Berichte zur Finanzlage

Recent updates

Frazier Lifesciences SPAC said in talks to take NewAmsterdam Pharma public

Jul 19

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: FLAC has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Langfristige Verbindlichkeiten: FLAC has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: FLAC is debt free.

Schulden abbauen: FLAC's has negative shareholder equity, so we do not need to check if its debt has reduced over time.

Schuldendeckung: FLAC has no debt, therefore it does not need to be covered by operating cash flow.

Zinsdeckung: FLAC has no debt, therefore coverage of interest payments is not a concern.


Bilanz


Entdecken Sie finanziell stabile Unternehmen